USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	061179/0202			Pages:	15
		Recorded:	09/22/2022
Attorney Dkt #:	1789918 PAT
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 26

Patent #:	8217010	Issue Dt:	07/10/2012	Application #:	11360236	Filing Dt:	02/22/2006
Publication #:	US20060211617	Pub Dt:	09/21/2006
Title:	METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF SOLID TUMORS

Patent #:	8394757	Issue Dt:	03/12/2013	Application #:	11845648	Filing Dt:	08/27/2007
Publication #:	US20080318846	Pub Dt:	12/25/2008
Title:	SENSITIZATION OF TUMOR CELLS TO RADIATION THERAPY THROUGH THE ADMINISTRATION OF ENDOTHELIN AGONISTS

Patent #:	8026216	Issue Dt:	09/27/2011	Application #:	12101008	Filing Dt:	04/10/2008
Publication #:	US20080253994	Pub Dt:	10/16/2008
Title:	METHODS AND COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8815953	Issue Dt:	08/26/2014	Application #:	12381467	Filing Dt:	03/12/2009
Publication #:	US20090234022	Pub Dt:	09/17/2009
Title:	FORMULATIONS OF VITAMIN K ANALOGS FOR TOPICAL USE

Patent #:	8030278	Issue Dt:	10/04/2011	Application #:	12390376	Filing Dt:	02/20/2009
Publication #:	US20090155206	Pub Dt:	06/18/2009
Title:	METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8440620	Issue Dt:	05/14/2013	Application #:	13220358	Filing Dt:	08/29/2011
Publication #:	US20110315575	Pub Dt:	12/29/2011
Title:	METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8349802	Issue Dt:	01/08/2013	Application #:	13220373	Filing Dt:	08/29/2011
Publication #:	US20110311481	Pub Dt:	12/22/2011
Title:	METHODS AND COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8703709	Issue Dt:	04/22/2014	Application #:	13491408	Filing Dt:	06/07/2012
Publication #:	US20120245105	Pub Dt:	09/27/2012
Title:	METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF SOLID TUMORS

Patent #:	8642026	Issue Dt:	02/04/2014	Application #:	13707807	Filing Dt:	12/07/2012
Publication #:	US20130101552	Pub Dt:	04/25/2013
Title:	METHODS AND COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8729023	Issue Dt:	05/20/2014	Application #:	13711519	Filing Dt:	12/11/2012
Publication #:	US20130102543	Pub Dt:	04/25/2013
Title:	METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Patent #:	8957014	Issue Dt:	02/17/2015	Application #:	13761043	Filing Dt:	02/06/2013
Publication #:	US20130150649	Pub Dt:	06/13/2013
Title:	SENSITIZATION OF TUMOR CELLS TO RADIATION THERAPY THROUGH ADMINISTRATION OF ENDOTHELIN AGONISTS

Patent #:	9308235	Issue Dt:	04/12/2016	Application #:	13890938	Filing Dt:	05/09/2013
Publication #:	US20130338079	Pub Dt:	12/19/2013
Title:	TREATMENT OF PRIMARY AND METASTATIC CARCINOMA

Patent #:	10022421	Issue Dt:	07/17/2018	Application #:	15061821	Filing Dt:	03/04/2016
Publication #:	US20160287660	Pub Dt:	10/06/2016
Title:	TREATMENT OF PRIMARY AND METASTATIC CARCINOMA

Patent #:	11541012	Issue Dt:	01/03/2023	Application #:	16257684	Filing Dt:	01/25/2019
Title:	COMPOSITIONS COMPRISING DISODIUM LEVOFOLINATE

Patent #:	11267858	Issue Dt:	03/08/2022	Application #:	16428351	Filing Dt:	05/31/2019
Publication #:	US20200377567	Pub Dt:	12/03/2020
Title:	METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX

Patent #:	11510922	Issue Dt:		Application #:	16757072	Filing Dt:	04/17/2020
Publication #:	US20200261455	Pub Dt:	08/20/2020
Title:	INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES

Patent #:	11684655	Issue Dt:	06/27/2023	Application #:	16996635	Filing Dt:	08/18/2020
Publication #:	US20210008166	Pub Dt:	01/14/2021
Title:	NOVEL METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX

Patent #:	NONE	Issue Dt:		Application #:	17250258	Filing Dt:	12/22/2020
Publication #:	US20210145834	Pub Dt:	05/20/2021
Title:	COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17250259	Filing Dt:	12/22/2020
Publication #:	US20210260064	Pub Dt:	08/26/2021
Title:	POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17275290	Filing Dt:	03/11/2021
Publication #:	US20220040180	Pub Dt:	02/10/2022
Title:	KITS AND METHODS FOR TREATING CANCERS

Patent #:	11883402	Issue Dt:	01/30/2024	Application #:	17275382	Filing Dt:	03/11/2021
Publication #:	US20220056011	Pub Dt:	02/24/2022
Title:	CRYSTALLINE FORMS OF A QUINAZOLINE COMPOUND AND ITS HYDROCHLORIDE SALTS

Patent #:	NONE	Issue Dt:		Application #:	17278397	Filing Dt:	03/22/2021
Publication #:	US20210353627	Pub Dt:	11/18/2021
Title:	NOVEL QUINAZOLINE EGFR INHIBITORS

Patent #:	NONE	Issue Dt:		Application #:	17374302	Filing Dt:	07/13/2021
Publication #:	US20220016212	Pub Dt:	01/20/2022
Title:	METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF G-CSF PROTEIN COMPLEX

Patent #:	NONE	Issue Dt:		Application #:	17586872	Filing Dt:	01/28/2022
Publication #:	US20220153799	Pub Dt:	05/19/2022
Title:	Methods of Treatment Using G-CSF Protein Complex

Patent #:	NONE	Issue Dt:		Application #:	17637304	Filing Dt:	02/22/2022
Publication #:	US20220296598	Pub Dt:	09/22/2022
Title:	Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof

Patent #:	NONE	Issue Dt:		Application #:	17781639	Filing Dt:	06/01/2022
Publication #:	US20230027238	Pub Dt:	01/26/2023
Title:	METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX

Assignors

SPECTRUM PHARMACEUTICALS, INC.

Exec Dt:

09/21/2022

ALLOS THERAPEUTICS, INC.

Exec Dt:

09/21/2022

TALON THERAPEUTICS, INC.

Exec Dt:

09/21/2022

Assignee

SLR INVESTMENT CORP., AS COLLATERAL AGENT

500 PARK AVENUE, 3RD FLOOR

NEW YORK, NEW YORK 10022

Correspondence name and address
	JAY DASILVA
	1025 CONNECTICUT AVE., NW, STE. 712
	COGENCY GLOBAL INC.
	WASHINGTON, DC 20036

Search Results as of: 05/26/2024 04:36 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6